Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What are you talking about? Makes no sense here or on Earth 2.
Checked on the Nevada filings through their Silver Flume Business Portal and nothing comes up when you click on the View button. Can you summarize what you're referring to. Are they trying to go private? They can't reverse split for 2 years according to a recent post here..
According to Investopedia, they need to compensate shareholders if they go private.
The fact that this CE removal has taken 10 months certainly does lend itself to arguments that common shareholders could be in trouble here.
Would appreciate any additional clarifications from you.
Hope I can receive your messages.
Thanks for your dd here
Now take a deep breath and say: "It's a wonderful day in the neighborhood." Don't you feel better already.
Ha ha
Been on Earth 1 lately
What are we betting on with BDPT? Let's remember the following:
1. Management has not been paid for several years and is taking compensation in the form of stocks.
2. The company issues Audited financials
Can anyone name one other pinky where that is occurring?
3. Management has superb scientific skills and credentials. Drs. Jacobs, Liu, and Nabokova are world class scientists.
4. Dr. Liu, now a Director of Livestock, owns $780 million in patents
5. We're scheduled to receive free shares in a Livestock spin-off
Yes there are few revenues at this point, but that could change dramatically in the not too distant future. And activities related to Dr. Liu's patents could begin to change things significantly as well.
All in all, the positive/negative ratio here looks very inviting to me.
Hi SR,
Hope all's well with you. Haven't seen any posts in quite awhile. Are you still holding? What are thoughts on the latest developments and the CE removal?
Best,
GS
Fantastic news. These guys are all world-class, gold standard folks.
How can OTC not remove that CE with company events like this. Given this PR and the Datron purchase, it's not hard to see the share prie at least .10 + once the CE is removed and trading egins again in U.S.
Things could very exciting real fast here.
sorry, corrections needed for earlier post:
should be 1 new Livestock for every 10 BDPT, leads to 150 million outstanding Livestock shares
and 1 new for every 5, leads to 300 million outstanding Livestock shares
If you now own a million BDPT shares, at those conversion rates, you'd now have either 100,000 or 200,000 free Livestock shares.
And if their shares ever moved into the penny range you could be doing very well with those freebies.
Anyone care to speculate about the ratio for the forthcoming Livestock Share Spin off?
With the new 250 million share offering the total outstanding shares is now around 1.5 billion shares
A ratio of 1 new Livestock share for every 100 BDPT shares would result in Livestock having a total of 150 million shares outstanding, a very small total for a pink sheet stock.
1 new for every 50 BDP would result in Livestock with a total of 300 million O/S shares
1 new for 25 BDPB leads to 600 million O/S Livestock shares
And so on.
Comments welcome
Who Owns the Patents for $570 million and $210 million? Dr. Liu of DBPT/Livestock does. And why wouldn't he be motivated to help the company in every way?
Let's thank Powerbattles and his DD in post #10755 for all the details on these patents.
So, while the company might not directly own these pattents, one of their major Directors does.
What are you talking about? And can you let us see where you're getting your info from.
Part of that PB quotes says:
"All my years of investing and trading I never received any compensation from anyone".
Doesn't that answer the question of whether ANYONE--THE COMPANY OR OTHERS-- has compensated him?
Great stuff. It's probably been at least a year since we got a detailed Shareholders Letter.
Don't you think we're long past due on that and the CE situation as well. After 10 months with the CE , it's hard to believe that they would be prohibited from commenting on that
Maybe if more of us raised these issues we get some public info.
3F,
I'm confused here. PB has posted today (#18251) that he never received any compensation from DBPT
"If you read the filings nobody in the company, received any compensation. Why are they treating me differently? To answer your question. All my years of investing and trading I never received any compensation from anyone".
Does that not answer your question? What more does he need to say?
Do you have evidence for that claim?
They supposedly have $100 + million in drone contracts.
1.Who's holding the price low and why?
2.I don't think they can do a reverse split while the CE is on
3. They can't move to Nasdaq, let's say, unless the share price is at least $4.00
So, I don't know what you are talking about here.
That would be great too. But nothing matters for us shareholders unless that CE is removed. Without that, we've got nothing.
Re: Dr. Liu's $210,000,000 Patent
Here's Powerbattles material from the same post on the $210,000,000 also owned by Dr. Liu; and a 9 ,8 million patent owned by DBPT
The patent number US 8,114,444 B2. is Valued at US$210,000,000 by Grant Thornton.
https://patents.google.com/patent/US8114444B2/en
It is titled Pharmaceutical Composition Containing Momordica Charantia L. Extracts for Lowering Blood Glucose. The patent was filed by Yaguang Liu on October 26, 2009, and granted on February 14, 2012.
According to a report by Mordor Intelligence, the global market for blood glucose monitoring is expected to grow from USD 21 billion in 2023 to USD 30.79 billion by 2028 at a CAGR of 7.82% during the forecast period (2023-2028). The market is estimated to reach a value of USD 29 billion by 2027.
https://www.mordorintelligence.com/industry-reports/global-blood-glucose-monitoring-market-industry
According to The Washington Post, President Joe Biden’s administration has released a list of 10 drugs for which the federal government will take a first-ever step: negotiating drug prices directly with the manufacturer. Among the first drugs that will be targeted for price negotiations are the diabetes drug Jardiance and blood thinner Eliquis.
https://www.washingtonpost.com/business/2023/08/29/medicare-prescription-drug-negotiations-biden-inflation/542f8234-4621-11ee-b76b-0b6e5e92090d_story.html
The patent describes a new sustained release drug preparation comprising such and inclusion complex of a medical compound with safe botanic drug (SBD), which sustains or retards the dissolution and release of the SBD at a controlled rate from the inclusion complex and hence from the drug preparation containing the SBD, so as to maintain the concentration of the SBD in blood at an effective level for prolonged time. SBD contains Kuguasu (KU) and saponins of Kugua (SAK). SBD is very safe and it is used for treating and preventing diabetes.
Blood glucose, also known as blood sugar, is the amount of glucose present in the blood. Glucose is a type of sugar that comes from the food we eat and is used by the body for energy. The body regulates blood glucose levels to ensure that they remain within a healthy range. However, when blood glucose levels are too high, it can lead to a condition called hyperglycemia, which can cause damage to organs and tissues over time.
Lowering blood glucose levels is important for people with diabetes, a chronic condition that affects how your body processes glucose. In people with diabetes, the body either doesn’t produce enough insulin or doesn’t use it effectively. Insulin is a hormone that helps regulate blood glucose levels by allowing cells to take up glucose from the bloodstream. When insulin is not working properly, blood glucose levels can become too high, leading to hyperglycemia. Over time, hyperglycemia can cause damage to organs and tissues throughout the body.
The U.S. Patent 9,783,432B is owned by BioAdaptives, Inc.
The patent was acquired from inventor Thomas J. Mohr by BioAdaptives, Inc. in February 2022. The technology operates to “embed” molecules of oxygen in water, rather than suspending gaseous oxygen, providing a longer-term aerobic benefit, including performance, e
Typo Correction: should be $570,000,000
Re: Who Owns the Patents?. Read below, taken from a post by Powerbattles #10755
The patent for $579,000.000 is owned by Dr. Liu, who is now a Director of the company (Livestock Spin-off I recall). Wouldn't he have a strong interest in working out agreements that are beneficial to BDPT?
The patent number US 9,622,970 B2. is valued at US$570,000,000 by Grant Thornton.
https://patentimages.storage.googleapis.com/7b/e8/07/5ae48f5931bde8/US9622970.pdf
https://patents.google.com/patent/US9622970B2/en
The patent number US 9,622,970 B2. It is titled Pharmaceutical Composition Containing Lutein and Antioxidant for Treating and Preventing Human Disease. The patent was filed on May 8, 2014, and granted on April 18, 2017 to Yaguang Liu. The U.S. Patent 9,622,970 B2 is a pharmaceutical composition containing lutein, astaxanthin, and antioxidant. The patent describes a new preparation that includes a complex of a medical compound with lutein, astaxanthin, and antioxidant. The new preparation includes stabilized liposome preparation, sustained release preparation, and polymeric micelles preparation which are used as delivery systems for lutein, astaxanthin, and antioxidant. The new preparation significantly increases the bioavailability of lutein and astaxanthin and is used for the treatment and prevention of eyes and other diseases.
BioAdaptives Inc. has signed a non-exclusive license agreement with LY Research Corporation to market the patented product for Eye Health due to Myopia and Presbyopia. The patent is valued at US$570,000,000 by Grant Thornton.
The global
Re: Shareholder Letter??
How many feel that the company is long past due on an Letter to shareholders about what's going on with the10 months-long CE? The letter should hopefully also include material on the very important Datron purchase.
This stock is currently trading in the .002 range. If the CE were removed it's quite possible the stock could hit .05 fairly quickly--a 25 fold increase!! Given that, why wouldn't management be doing everything possible to get it removed. Sure, you'll say that's just what they're doing. Well, we really need to hear from them about that. When was the last time tjhey PUBLICLY commented on the CE?
If this CE happened to a company you were managing, wouldn't you seek out people that had experience AND SUCCESS in working with the OTC to get the CE removed. I haven't seen that happen here. Have you?
Great Datron purchase. Great expected revenues from the combined companies--possibly around $200 million and nothing gets said about the CE.
More on the Share Structure of the Spin-off
Many of us are here because of the free shares from the spin-off. Given that, would it not be very helpful to have an informed discussion about the possible dimensions of that share swap. If investors had a better idea of the range of shares they might get, buying might be much stronger here.
Are we talking about a range of 1 new share for every 20 BPDT, or perhaps even less new shares than that, 1 new for every 50 BDPT. Or, more optimistically, 1 new for every 5 BPDT owned shares?
Is there a range that could be specified based on what spin-offs have occurred for other pink sheet stocks.
Or is the situation so complicated and ambiguous that no informed discussion can occur?
PB, re: Share Structure of the Spin-Off Company
I'm trying to imagine what a free share-spin off would look like. If we use the current 1.25 billion share authorized for BDPT as the number, a 1 new share for every 10 BDPT shares swap would leave the spinoff with only 125 million shares, which would be quite low for a Pink Sheet company.
Is it possible that the spin-off share issuance might be even better for us than 10 for 1,so that the total share count of the new company would be more than just a few hundred million? Is it possible we could get 1 share in the spin off for every 5 BDPT shares owned , making the new company's outstanding share total 250 million?
Or, is my reasoning here totally off base?
At any rate, keep up your great posts.
Could be. On the other hand maybe he's trying to speak with VP Bill M. who's with Schmidt in Lebanon and may be gone for a few. weeks. Just guessing.
It really is maddening that we have a CE on stock that, with the Datron purchase could be doing $200 million in revenue this year--CYBL ($100+ million) and Datron ($75 million); and .add in the State Dept. partnership thru Datron and their Defense Dept conacts as welll..
It seems to me that if the stock were trading it could easily be .10+
Comments welcome
Assuming Schmidt's there for business purposes. What do you think is going on there?
More on Bill Maadarani:
Bill Maadarani, Pres. of Datron, is also the Public Chairman of the Overseas Security Advisor Council, which partners with the U.S. STATE DEPARTMENT!!!
Overseas Security Advisory Council (OSAC)
Overseas Security Advisory Council (OSAC) Information
OSAC is a partnership between the U.S. Department of State and private-sector security community that supports the safe operations of U.S. organizations and personnel overseas through threat alerts, analysis, and peer network groups. The OSAC Program Office is headquartered in Washington, DC and is overseen by a 34-member public-private Council. OSAC membership includes 5,400+ organizations and 18,000+ individuals from U.S.-based corporate, nonprofit, academic, and faith-based groups of every size, all with overseas operations and personnel who are exposed to ever-evolving security issues. The OSAC community collaborates in regional- and sector-specific groups to keep members informed, connected, and better equipped to manage the complex security challenges around the world.
Website https://www.osac.gov/
Employees
81
Top Overseas Security Advisory Council (OSAC) Employees
2
781883XXXX 781245XXXX
Bill Maadarani
Public Chairman
Dearborn Heights, MI, US
2
dtwc.com osac.gov
3
321541XXXX 760597XXXX 586405XXXX
Kayla Rose
Program Manager
Washington, DC, US
1
rhodes.edu
2
415250XXXX 415435XXXX
Related Companies
Corpus Christi Housing Authority & Affiliates
Corpus Christi Housing Authority & Affiliates
42
$1m
Coastal Bend Council of Governments
Coastal Bend Council of Governments
28
Learn More
More on Bill Maadarani:
Bill Maadarani, Pres. of Datron, is also the Public Chairman of the Overseas Security Advisor Council, which partners with the U.S. STATE DEPARTMENT!!!
Overseas Security Advisory Council (OSAC)
Overseas Security Advisory Council (OSAC) Information
OSAC is a partnership between the U.S. Department of State and private-sector security community that supports the safe operations of U.S. organizations and personnel overseas through threat alerts, analysis, and peer network groups. The OSAC Program Office is headquartered in Washington, DC and is overseen by a 34-member public-private Council. OSAC membership includes 5,400+ organizations and 18,000+ individuals from U.S.-based corporate, nonprofit, academic, and faith-based groups of every size, all with overseas operations and personnel who are exposed to ever-evolving security issues. The OSAC community collaborates in regional- and sector-specific groups to keep members informed, connected, and better equipped to manage the complex security challenges around the world.
Website https://www.osac.gov/
Employees
81
Top Overseas Security Advisory Council (OSAC) Employees
2
781883XXXX 781245XXXX
Bill Maadarani
Public Chairman
Dearborn Heights, MI, US
2
dtwc.com osac.gov
3
321541XXXX 760597XXXX 586405XXXX
Kayla Rose
Program Manager
Washington, DC, US
1
rhodes.edu
2
415250XXXX 415435XXXX
Related Companies
Corpus Christi Housing Authority & Affiliates
Corpus Christi Housing Authority & Affiliates
42
$1m
Coastal Bend Council of Governments
Coastal Bend Council of Governments
28
Learn More
Thanks for the update
Great post!!! Keep informing us.
Seen any responses from Brett Rosen about the Datron purchase?
Re: CYBL share buyback
Awhile back, CYBL publicly announced that they were going to spend about $20 million on a share buyback. I would assume they can't do that while the CE is on since the stock can't be bought in the U.S..
At any rate, if the CE is lifted and share price is still less than .005 it would seem a very large number of shares could be bought, thus reducing the float very dramatically.
Does the Datron purchase speed up the OTC process for removing the CE?
Comments welcome.
JRF,
While we're waiting here, you might check out BDPT.: Management takes no salary. It's Audited reporting and has Patents valued at $780,000,000!! Make sure to read the posts by powerbattles, an amazing researcher.
It's currently trading at .0031. Very high risk, but worth checking out.
.
Forgot to add: Check out the postings at BDPT by Powerbattles, an amazing researcher.
While we're waiting here, you might check out BDPT.: Management takes no salary. It's Audited reporting and has Patents valued at $780,000,000!!
It's currently trading at .0033. Worth checking out.
Thanks for all your DD here.
Great info. Thanks much
Snow,
Hope all's well with you. Let me return your earlier favor with a recommendation to check out BDPT and make sure to read the posts by Powerbattles--a really great researcher.
It's trading at .0030 but seems to have great potential. Management takes no salary, they're AUDITED., and have $780,000,000 in PATENTS.
Regards,
Gosox
Exactly. I guess they've never been to Vancouver, Toronto, Montreal, etc. And hardly anyone's dying of gun wounds there as well!! Way too much sanity for me!!!
Welcome to wackadoo land and Q-Anon crazies. And now they also want to kill Gen. Milley for treason. Yeah, he's the guy who took vital national defense secrets and stored them in a bathroom at his resort!!!
More specifically, I gotta believe this Datron acquisition is a a big deal, but with the CE still on we Americans are stuck with an almost zero share price.
Rosen now says he thinks the CE willl off by 12/31. Geeze, that's 3 more months on top of the previous 9. Not real happy about that prediction, but i guess it's better than Never.